Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 6/20 | 0.70 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.64 |
| ▸ | TBXAS1 | P24557 | 5/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | BCHE | P06276 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL8937697 | 0.98 | FFAR1 (0.68) | FFAR1KEAP1TBXAS1LMNAALDH1A1 | |
| SCHEMBL26111039 | 0.98 | FFAR1 (0.68) | FFAR1KEAP1TBXAS1LMNAALDH1A1 | |
| SCHEMBL12646445 | 0.88 | FFAR1 (0.69) | FFAR1KEAP1TBXAS1CA1CA2 | |
| SCHEMBL1624984 | 0.87 | HDAC3 (0.67) | FFAR1TBXAS1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL6644828 | 0.85 | HDAC3 (0.64) | FFAR1TBXAS1ALDH1A1 | |
| SCHEMBL1677606 | 0.85 | MAPT (0.66) | FFAR1TBXAS1ALDH1A1 | |
| Phenyl Propionic Acid SCHEMBL8586101 | 0.85 | KEAP1 (0.76) | FFAR1KEAP1TBXAS1LMNAALDH1A1 | |
| SCHEMBL6573723 | 0.84 | FFAR1 (0.52) | FFAR1LMNANPY5RTDP1 | |
| SCHEMBL27581983 | 0.84 | MMP12 (0.61) | FFAR1KEAP1TBXAS1LMNAALDH1A1 | |
| SCHEMBL8816958 | 0.84 | MAPT (0.69) | FFAR1TBXAS1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116936810-B | Positive pole piece of sodium ion battery and sodium ion battery | 天鹏锂能技术(淮安)有限公司 | 2023-12-12 | — | — | CN | claimed |
| CN-116936810-A | Positive pole piece of sodium ion battery and sodium ion battery | 天鹏锂能技术(淮安)有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-116462661-A | Deuterated 3- (pyridin-4-yl) propionic acid compound, and preparation method and medical application thereof | 深圳信立泰药业股份有限公司 | 2023-07-21 | — | — | CN | claimed |
| CN-109863146-B | Biaryl compounds as immunomodulators | 百时美施贵宝公司 | 2023-02-28 | — | — | CN | claimed |
| US-9833768-B2 | Affinity reagents for protein purification | IMPOSSIBLE FOODS INC. (US) | 2017-12-05 | — | — | US | claimed |
| US-20170320041-A1 | AFFINITY REAGENTS FOR PROTEIN PURIFICATION | IMPOSSIBLE FOODS INC. | 2017-11-09 | — | — | US | claimed |
| US-9737875-B2 | Affinity reagents for protein purification | IMPOSSIBLE FOODS INC. (US) | 2017-08-22 | — | — | US | claimed |
| WO-2017092759-A1 | GEPHYRIN BINDING PEPTIDES AND USES THEREOF | UNIVERSITY OF COPENHAGEN (DK) | 2017-06-08 | — | — | WO | claimed |
| CN-104620104-B | Affinity Reagents for Protein Purification | 非凡食品有限公司 | 2017-03-01 | — | — | CN | claimed |
| US-20080287492-A1 | Alkylpyridyl Quinolines as Nk3 Receptor Modulators | ASTRAZENECA AB (SE) | 2008-11-20 | — | — | US | claimed |
| CN-101282961-A | Alkylpyridyl quinolines as NK3 receptor modulators | ASTRAZENECA AB (SE) | 2008-10-08 | — | — | CN | claimed |
| EP-1915361-A1 | ALKYLPYRIDYL QUINOLINES AS NK3 RECEPTOR MODULATORS | AstraZeneca AB (SE) | 2008-04-30 | — | — | EP | claimed |
| WO-2007018466-A1 | ALKYLPYRIDYL QUINOLINES AS NK3 RECEPTOR MODULATORS | ASTRAZENECA AB (SE) | 2007-02-15 | — | — | WO | claimed |
| EP-4029868-B1 | MCL-1 INHIBITORS | GILEAD SCIENCES INC (US) | 2026-05-20 | — | — | EP | disclosed |
| US-12552866-B2 | Internalizing binding molecules targeting receptors involved in cell proliferation or in cell differentiation | LINXIS B.V. (NL) | 2026-02-17 | — | — | US | disclosed |
| US-20250333782-A1 | COMPOSITIONS INCLUDING AQUEOUS AMINE BORANE COMPLEXES AND POLYNUCLEOTIDES, AND METHODS OF USING THE SAME TO DETECT METHYLCYTOSINE OR HYDROXYMETHYLCYTOSINE | ILLUMINA INC (US) | 2025-10-30 | — | — | US | disclosed |
| US-4172075-A | Fluoro-steroids and processes for their manufacture | CIBA-GEIGY CORPORATION (US) | 1979-10-23 | — | — | US | disclosed |
| US-4145344-A | BICYCLOMYCIN DERIVATIVES | CIBA-GEIGY CORPORATION (US) | 1979-03-20 | — | — | US | disclosed |
| US-4092310-A | Difluorosteroids and processes for their manufacture | CIBA-GEIGY CORPORATION (US) | 1978-05-30 | — | — | US | disclosed |
| US-4052421-A | 13-ETHINYL-STEROIDS AND PROCESSES FOR THEIR MANUFACTURE | CIBA-GEIGY CORPORATION (US) | 1977-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170320041-A1 | AFFINITY REAGENTS FOR PROTEIN PURIFICATION | RAB5IF, MRPL21, RPS27A | FFAR1 4755/4885KEAP1 2336/4885TBXAS1 2861/4885 |
| US-12552866-B2 | Internalizing binding molecules targeting receptors involved in cell proliferation or in cell differentiation | PDGFRB, PDGFRA, HAVCR2 | FFAR1 1506/4885KEAP1 3893/4885TBXAS1 2957/4885 |
| US-20080287492-A1 | Alkylpyridyl Quinolines as Nk3 Receptor Modulators | ADORA3, KCNA3, TACR1 | FFAR1 477/4885KEAP1 3002/4885TBXAS1 1445/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.